Program Development & Operational Support

Theranostics and Radioligand Therapy (RLT) are expanding treatment options for patients with select cancers and creating new opportunities for hospitals to grow advanced nuclear medicine services.

HeartCare Imaging partners with hospitals and physicians to evaluate, develop, and support compliant, sustainable theranostics programs, drawing on decades of experience in nuclear medicine operations, staffing, accreditation, and regulatory oversight.

What Are Theranostics?

Theranostics combine molecular imaging and targeted radiopharmaceutical therapy using the same biological target to diagnose and treat disease.

This approach allows clinicians to:

  • Identify appropriate patients through diagnostic imaging
  • Deliver targeted radiation therapy
  • Monitor treatment response using established nuclear medicine techniques

Current clinical applications include prostate cancer and neuroendocrine tumors, with additional indications emerging.

Radioligand Therapy (RLT)

Radioligand Therapy is a form of theranostics in which a radioactive isotope is bound to a targeting molecule that selectively delivers radiation to cancer cells.

Launching an RLT program requires coordination across:

  • Nuclear medicine
  • Oncology
  • Radiation safety
  • Pharmacy and nursing
  • Hospital administration

HeartCare Imaging helps institutions navigate these requirements with a structured, experienced approach.

How HeartCare Imaging Supports Theranostics Programs

HeartCare Imaging provides consulting and operational support tailored to each institution, including:

Program Assessment

  • Evaluation of clinical and operational readiness
  • Review of referral patterns and service demand
  • Financial and reimbursement considerations

Program Development

  • Workflow and staffing model design
  • Facility and equipment planning support
  • Policy, protocol, and documentation guidance

Staffing & Operations

  • Nuclear medicine staffing support
  • Ongoing operational oversight and quality assurance
  • Coordination with hospital leadership and clinical teams

Compliance & Safety

  • Radiation safety and regulatory guidance
  • Radiation Safety Officer (RSO) services
  • Accreditation and audit preparedness

Education & Alignment

  • Physician and staff education
  • Support for referral pathway development
  • Alignment between nuclear medicine and oncology services

Our Approach

HeartCare Imaging operates under a consultative, partnership-based model.
We do not bill for clinical procedures.

Instead, we work alongside hospitals to ensure theranostics programs are:

  • Clinically appropriate
  • Operationally sound
  • Compliant with regulatory requirements
  • Financially sustainable

Many of our client relationships span 25+ years, reflecting a shared focus on long-term success.

HCI group of people standing together talking about business matters

Who We Work With

  • Academic medical centers
  • Community hospitals
  • Critical Access Hospitals

Each engagement is customized based on institutional goals, resources, and patient populations.

Get Started

Interested in exploring a theranostics or RLT program?

HeartCare Imaging welcomes the opportunity to discuss whether theranostics are a fit for your institution and how we can support program development and operations.

Contact us to request a consultation.